Andrea Weiland-Waibel, PhD Explicat Pharma

Andrea is a Pharmacist with a Ph.D. in Pharmaceutical Technology from the Ludwig Maximilians University Munich. She has held several leadership positions within Pfizer, working as project manager in process technology and being responsible for technology transfer & process development, mainly on sustained release solid dosage forms. Within R&D she was responsible scientist for pharmaceutical development (Phase I - III, candidate characterization and lyophilisation projects). After joining IDEA AG, a biotechnology company based in Munich, Andrea Weiland held the position of director pharmaceutical development and was responsible for process technology development, drug delivery system development (liposomes, patches), formulation of recombinant proteins, analytical development, and clinical supplies manufacture; she also served as IDEA`s QP. She is founder of Explicat Pharma GmbH and managing director since 2005.

Hers and her team`s experience cover the development of biopharmaceuticals (e. g. recombinant factor VIII), development of lyoformulations and lyocycles, analytical development and related QA as well as regulatory issues. Andrea Weiland is qualified person and a member of AAPS as well as several other professional institutions based in Europe.